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Abstract
Background: Developing effective methods for measuring the health impact of social franchising programs is vital
for demonstrating the value of this innovative service delivery model, particularly given its rapid expansion
worldwide. Currently, these programs define success through patient volume and number of outlets, widely
acknowledged as poor reflections of true program impact. An existing metric, the disability-adjusted life years
averted (DALYs averted), offers promise as a measure of projected impact. Country-specific and service-specific,
DALYs averted enables impact comparisons between programs operating in different contexts. This study explores
the use of DALYs averted as a social franchise performance metric.
Methods: Using data collected by the Social Franchising Compendia in 2010 and 2011, we compared franchise
performance, analyzing by region and program area. Coefficients produced by Population Services International
converted each franchise’s service delivery data into DALYs averted. For the 32 networks with two years of data
corresponding to these metrics, a paired t-test compared all metrics. Finally, to test data reporting quality, we
compared services provided to patient volume.
Results: Social franchising programs grew considerably from 2010 to 2011, measured by services provided (215%),
patient volume (31%), and impact (couple-years of protection (CYPs): 86% and DALYs averted: 519%), but not by
the total number of outlets. Non-family planning services increased by 857%, with diversification centered in Asia
and Africa. However, paired t-test comparisons showed no significant increase within the networks, whether
categorized as family planning or non-family planning. The ratio of services provided to patient visits yielded
considerable range, with one network reporting a ratio of 16,000:1.
Conclusion: In theory, the DALYs averted metric is a more robust and comprehensive metric for social franchising
than current program measures. As social franchising spreads beyond family planning, having a metric that
captures the impact of a range of diverse services and allows comparisons will be increasingly important. However,
standardizing reporting will be essential to make such comparisons useful. While not widespread, errors in self-
reported data appear to have included social marketing distribution data in social franchising reporting, requiring
clearer data collection and reporting guidelines. Differences noted above must be interpreted cautiously as a result.
Background
Private providers outnumber public providers in nearly
all low- and middle-income countries (LMICs), deliver-
ing more than 50% of all healthcare services in Africa
and Asia and more than 70% of all healthcare in the
most populous countries in these regions: Nigeria, India,
Pakistan, Bangladesh, and Indonesia [1]. Given private
health facilities’ large share of national health markets,
LMIC national health systems are increasingly chal-
lenged to ensure these private providers sufficiently
advance public health goals and adhere to national stan-
dards of care.
Social franchising is an innovative way of leveraging
existing private sector infrastructure in LMICs to serve
these national public health goals. To do so, social fran-
chising promotes and improves clinical services among
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existing private providers through technical assistance
and the application of social marketing techniques, a
health intervention that has proven successful in foster-
ing widespread access to and use of public health com-
modities in LMIC countries [2,3]. As the fastest growing
mechanism for engaging private practitioners in national
public health initiatives, this social franchising approach
is supported by a highly collaborative community of
practice and a growing body of evidence that demon-
strates social franchising’s ability to improve service
quality, increase access to essential services, and serve
the poor [4,5].
Social franchises engage existing for-profit, private
clinics in a contractual exchange. The franchise program,
nearly always run by a non-governmental organization
(NGO), builds providers’ capacity in new clinical meth-
ods, clinic management, business skills, and marketing
and advertising techniques. Doing so builds demand for
the health services offered. The program also organizes
ongoing education and technical support as well as
access to subsidized commodities and medicines which
are often unavailable. Service quality is further supported
through franchise-mediated linkages to private and
national referral systems. In exchange, providers who
enroll as franchisees commit to providing the health ser-
vices that the implementing organization prioritizes,
often low-margin services such as family planning or
antenatal care, or socially unattractive services such as
treatment for tuberculosis (TB) or HIV/AIDS. Franchise
providers also are required to adhere to clearly defined
clinical, reporting, and pricing practices. Increased client
load, the resulting increase in profits, training opportu-
nities, and reputation enhancement are the most fre-
quently cited motivations for providers to join a social
franchise [6,7].
Begun in the early 1990s in Pakistan and Nepal, social
franchising programs have steadily expanded throughout
the developing world; as of June 2012, more than 50 pro-
grams operate in 35 countries [8] (see map, Figure 1).
Initially, participating clinics and providers offered only
family planning services, but many franchise service port-
folios have expanded in recent years to include pediatric
and maternal care as well as infectious disease testing
and treatment, among others. More than half of the
world’s social franchise programs now offer a range of
non-family planning services, and the number of pro-
gram areas addressed by each franchise is growing each
year [8]. While social franchises are often linked to large-
scale social marketing programs which promote and dis-
tribute non-clinical health commodities (e.g., condoms or
mosquito bednets) through retail outlets, the franchises
themselves are, by definition, focused on clinical service
delivery. Currently, two large international NGOs, Popu-
lation Services International (PSI) and Marie Stopes
International (MSI), operate or support the majority of
global social franchise programs, 25 and 10 programs
respectively [9,10].
The growth in the number of programs has led to the
development of a global community of practice among
social franchisors. Coordinated by the University of Cali-
fornia, San Francisco (UCSF)’s Global Health Group, this
network of social franchising implementors facilitates
information exchanges and supports almost all of the
known social franchising programs, compiling data
annually about its members in a Compendium of Clinical
Social Franchising Programs [8,11]. The Social Franchising
Compendia are comprised of both large and small fran-
chise programs. Large programs are defined as reporting
an operating budget of more than $500,000 per year and
including more than 50 member clinics. From 2010-2011,
the Compendia gathered data on 58 social franchise net-
works, spanning Asia, Africa, and Latin America.
Increased confidence in this service delivery model on
the part of donor agencies and NGOs accounts, in part,
for the rapid expansion of social franchising. These stake-
holders believe that franchises increase access to impor-
tant clinical services by extending the geographic reach of
the government healthcare system. Related clinical service
models, such as NGO delivery or one-time training pro-
grams, face challenges in providing widely distributed ser-
vices. It can be difficult for these models to meet high
quality standards at outlets while offering only a low
volume of services to a small catchment area and patient
base. In contrast, by leveraging existing infrastructure and
in situ skilled providers, social franchise networks are the-
oretically able to assure quality at comparatively low cost,
even in low volume settings [2].
As with any health intervention, understanding the
health impact of social franchising programs is essential,
to inform decision making and to demonstrate the viabi-
lity and value of this innovative approach. Currently, pro-
grams track a number of service delivery measures: the
number of patient visits, not tracked by individual
patients, for any cause or service (called “patient volume”
hereafter); the number of clinics operating (called “num-
ber of outlets” hereafter); and (rarely) the number of pre-
vention or treatment interventions received by patients
(called “services provided” hereafter). Family planning-
focused programs frequently track and report CYPs, a
measure of projected impact that can be applied to all
family planning methods based on weights to approxi-
mate the number of years a method safeguards against
pregnancy and the number of products or services pro-
vided. For example, 120 condoms are considered to pro-
tect the couple from pregnancy for one year, and are
thus, equal to one CYP, as are 13 cycles of monthly con-
traceptive pills, or .26 of a 5-year implant. (Note that the
average implant is estimated to provide only 3.8 CYPs,
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not five, because some 5-year implants are removed early;
hence .26 implants leads to one CYP.) [12].
These process measures are widely acknowledged as
crude and poorly correlated with the true health impact
that these programs likely achieve [13]. Patient volume
and number of outlets have inherent problems: the for-
mer includes no information on severity of disease,
while the latter does not reflect information on the
patients served or the types of illnesses and health con-
ditions treated [14]. Although the CYP metric is a good
aggregate measure of family planning program projected
impact, it is a metric of protection, not health impact,
and it is limited to one program area only. As social
franchises increasingly expand their portfolio of services
beyond family planning, CYPs will capture only a small
portion of all care offered.
Program managers and donors currently seek more
robust measures of program impact, both to benchmark
program performance against appropriate comparators,
and to track year-to-year improvement [15-18]. A stan-
dardized metric for projected health impact would enable
these program comparisons and allow for more accurate
assessments of social franchising program variations,
after accounting for changes in population health and
service delivery. Such a method would also provide a
basis for more accurate analysis of the cost-effectiveness
of complex delivery systems and programs.
An existing metric, DALYs averted, offers promise as an
impact measure of social franchising programs. This
metric is based on the DALY, the standard unit represent-
ing disease burden in a population, originally developed
for the World Bank in 1990 and adopted by the World
Health Organization (WHO) in 2000 as part of the Global
Burden of Disease Study [19,20]. Disease burden can be
expressed as the number of DALYs lost due to a health
condition, either from premature death (mortality) or dis-
ability (morbidity), as compared to an ideal life expectancy
[20]. The DALYs averted measure, then, denotes the dis-
ability-adjusted life years that are not lost - or, are averted
- as a result of a health intervention. The attraction of
using a metric based on the DALY is that the DALY
incorporates both mortality and morbidity, it is widely
used by global development agencies, it enables compari-
son across countries on an standardized scale, and it can
be aggregated or disaggregated by disease [21,22].
The DALYs averted metric is intended conceptually to
be the inverse of DALYs in burden and thus benefits
from a growing understanding of what a DALY, as a unit,
Figure 1 Global growth of social franchising programs, 2003 versus 2012.
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is. Such attributes allow decision makers to use DALYs
for comparing the overall burden of disease due to TB,
malaria, diabetes, or other illnesses. Conversely, decision
makers can also compare projected DALYs averted for
understanding the potential to reduce burden with speci-
fic interventions, and to allocate resources based on these
data.
Despite its established importance in global burden of
disease assessment, the DALY has only recently been
adapted into a measure of the impact of healthcare inter-
ventions by service providers. Beginning in 2007, PSI
initiated the use of an impact metric based on the DALY.
In each of the 58 countries where PSI operated, research-
ers calculated a country- and disease-specific DALY coeffi-
cient for each prevention or treatment intervention [23].
These models project the impact of specific products and
services across a wide range of program areas, such as
male circumcision, malaria rapid diagnostic test kits,
intrauterine device (IUD) insertions, and pneumonia treat-
ment [24]. Note that PSI bases the DALYs averted metric
on models of health impact which are necessarily different
from the WHO and World Bank burden models of
DALYs. PSI has also never used age weighting in DALY
calculations.
PSI DALYs averted models are tailored to different dis-
eases and interventions. As a generalized description,
DALYs averted are calculated based on reduced risk in a
population and the corresponding years of healthy life
preserved. Using country-specific population and health
data, the reduced risk of death is calculated by applying
the demonstrated effectiveness of prevention or treat-
ment to baseline disease burden. To calculate impact in
DALYs averted, the reduction in mortality is multiplied
by the number of years between average age at death for
the targeted disease and ideal life expectancy. The ratio
of years lost from death to years lost from disability is
used to calculate the additional years that would be lost
to disability for the same disease. The result of this calcu-
lation is a DALYs averted coefficient, the impact of a sin-
gle product or service in years of healthy life preserved.
Other publications describe the PSI methodology in
more detail [24].
Each of PSI’s DALYs averted models projects health
impact from the use of one service or product delivered
(e.g., a safe child delivery or the sale of a packet of oral
rehydration salts (ORS) for pediatric diarrhea), producing
a coefficient for this unit. Besides being product- or ser-
vice-specific, this coefficient is also country-specific, as
the number of DALYs averted by any treatment or ser-
vice varies according to the national burden of disease.
For example, in a country with a low malaria burden, the
sale of a long-lasting, insecticide-treated net (LLIN) will
have a small coefficient whereas this coefficient will be
much larger in a country with higher incidence and
widespread malaria. Therefore, the DALYs averted coeffi-
cient for an LLIN in Nicaragua will differ sharply from
that used for an LLIN in Benin. To generate estimates of
the number of DALYs averted by a specific service or
product intervention, the coefficient is then applied to
the total number of services or products distributed
within the country during the past year. For example, the
LLIN coefficient for Benin is multiplied by the number of
LLINs distributed, resulting in the total number of
DALYs averted by the LLIN intervention in Benin.
The final model outputs for each intervention, DALYs
averted, can serve as a program management tool as these
outputs allow comparisons of impact between countries
and between different interventions offered within each
country program. Organizations can use the DALYs
averted metric to benchmark program impact and deter-
mine program emphasis and design, as described else-
where [25]. Thus far, both PSI and MSI have adopted
DALYs averted for internal program management use;
other organizations are considering doing the same.
For managing social franchising programs, the DALYs
averted metric would be useful for projecting program
impact, by applying the coefficients to reported service
delivery data, on a monthly, quarterly, or annual basis.
DALYs averted can be considered for specific interven-
tions within a health program area (e.g., HIV or family
planning) for a social franchise network, country, or
region. To understand the overall health impact of a social
franchise program, the DALYs averted across all individual
products or services can be summed. The resulting aggre-
gate will show an estimate of the health impact of family
planning services as well as the social franchising pro-
gram’s impact on malaria, diarrhea, and other targeted
health conditions. With this aggregate, comparisons of
overall effect between social franchising programs mana-
ged by different implementing organizations and operating
in different national contexts are possible because DALYs
averted adjusts for the burden of disease in each country.
Study goals
This study seeks to demonstrate the application of a sin-
gle, comprehensive health impact measure to social fran-
chising programs. Our principal goal is to present the use
of DALYs averted alongside currently used program out-
put and impact measures - patient volume, number of
outlets, number of services provided, and CYPs - to track
progress across a global set of social franchising net-
works. We describe changes in social franchising impact
over two years, 2010 to 2011, and highlight differences by
region and program area. We also review the strengths
and limitations of each of the individual metrics currently
used by social franchising programs. In doing so, we dis-
cuss opportunities to incorporate DALYs averted as a
social franchising metric, reviewing the programmatic
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decisions that could be informed by this metric. We hope
this study will provide insight into the benefits and chal-
lenges of establishing a standardized impact measure-
ment system for service delivery programs run by
multiple implementing organizations.
Methods
Data for this analysis comes from the 2010 and 2011 self-
reported programmatic and services data collected by the
Social Franchising Compendia for each year [8,11]. All
social franchising programs known to UCSF’s Global
Health Group at the end of each year are included in the
Social Franchising Compendia. To maximize the likeli-
hood that all active social franchises are captured, those
programs tracked by the Social Franchising Compendia
are compared on a quarterly basis with other lists of social
franchises (e.g., those compiled by the Center for Health
Market Innovation and the International Centre for Social
Franchising), in addition to conducting a thorough search
of programs referenced on the internet, and canvassing
donors and implementers.
Nearly all Social Franchising Compendia programs
voluntarily report service delivery data annually between
February and April, using either internet-based survey
forms or Adobe Portable Document Format (PDF) docu-
ments filled in by hand. Data are checked for empty
response cells and for consistency with program descrip-
tions. Programs report the total number of patient visits
(patient volume) and the treatments, procedures, and
products provided (services provided) for a wide range of
conditions and diseases. In addition, programs report a
range of aggregate program data, including the number
of clinics included in the social franchising network, the
number and type of providers per clinic, and the size of
annual operating budgets. Additional file 1 provides an
overview of the social franchising programs that are
Compendia members.
The key output measures emphasized in this study - ser-
vices provided, patient volume, and number of outlets -
were directly reported by the social franchising networks to
the Social Franchising Compendium. These annual service
delivery data formed the basis for calculating both DALYs
averted and CYPs. CYPs were calculated using the 2011
USAID conversion factors specific to each family planning
method, called CYP coefficients in this paper [12].
To apply DALYs averted to franchised program ser-
vices, we adopted the most widely used tools for estimat-
ing the number of DALYs averted from service delivery
data that we are aware of, the health impact estimation
models used by PSI. PSI’s DALYs averted models are
appealing for this analysis because of their breadth: these
models provide an estimate of per-unit impact of 44 dif-
ferent service and product interventions, many of which
are offered by social franchisors and used in the LMICs
where most social franchising programs are currently
located. Therefore, the country- and service-specific
DALYs averted coefficients produced by these models
can be easily applied to multiple social franchises, regard-
less of their program affiliation.
To estimate DALYs averted, we multiplied the appro-
priate PSI DALYs averted country- and service-specific
coefficients to the service delivery data reported by the
social franchising program of interest. For example, the
Bangladesh DALYs averted coefficients were used for
determining the number of DALYs averted by each of
the services offered by the Blue Star Bangladesh social
franchise. Once DALYs averted were calculated for each
service reported, we totalled all of them to produce an
aggregated estimate of the number of DALYs averted
for that social franchising program in either 2010 or
2011.
Among the full dataset reported to the Social Fran-
chising Compendium, certain services could not be
paired with coefficients for estimating DALYs averted
because of one of the following reasons: PSI did not
have a DALYs averted model for the intervention; the
PSI model did not include country data for the country
where the intervention was reported; or the social fran-
chise program reported insufficient information, prohi-
biting the pairing of the service with a DALYs averted
coefficient. Additional file 2 presents the full set of
interventions reported by social franchising networks.
Note that most, but not all, of these interventions could
be matched to a country- and intervention-specific coef-
ficient to estimate DALYs averted. All of the family
planning methods offered by social franchisors could be
converted to CYPs.
A total of 58 social franchising networks reported data
to the Social Franchising Compendium for the years 2010
and 2011, with 50 programs reporting data in 2010 [11]
and 51 programs doing so in 2011 [8]. Spanning three
continents and 36 countries, these social franchising net-
works vary in age and size, with Asian networks being the
oldest and largest. The oldest network is Sangini Franchis-
ing, launched in Nepal in 1994, while the youngest five
networks were launched in 2011 in Laos, Mozambique,
Sudan, Nicaragua, and Somaliland. Sub-Saharan Africa
has the largest number of social franchising programs
whereas Latin America has the fewest.
Fifty-one programs provided sufficient service delivery
data to enable the calculation of DALYs averted or CYPs
provided for 2010 or 2011. For the statistical analysis, we
included only those programs from this sample which pro-
vided data for both years (N = 32). Half of these (16 pro-
grams) are controlled by or affiliated with PSI. The
remaining half are either affiliated with MSI (6 programs),
the US-based NGO, DKT International (1 program), or
are independent (9 programs), meaning they are
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unaffiliated with an international NGO but may be linked
to a local NGO or private organization within the country.
While most of the non-PSI programs deliver healthcare in
the same countries where PSI works, social franchising
programs are also included from five countries where PSI
is not present: Bangladesh, Indonesia, Peru, the Philip-
pines, and Sierra Leone.
Data adjustments
Certain non-PSI program data required some data extra-
polation before we could derive the number of DALYs
averted based on PSI’s coefficients. For the five countries
where PSI does not currently work (and therefore, where
PSI has not yet determined country-specific coefficients
for each health intervention), we needed to infer the value
of the DALYs averted coefficients for that country. To do
so, we applied the average of the intervention coefficient
from countries in the same WHO region with a per-capita
gross domestic product (GDP) within 300% of the non-
PSI country. For example, to determine the Philippines
coefficients, we used an average of those developed by PSI
for Vietnam, Laos, and Cambodia. Once we identified the
coefficients for each of these countries, we followed the
process described above for calculating DALYs averted for
the social franchising programs in these five countries.
We also needed to adjust non-PSI program data to fit
the parameters used in PSI’s DALYs averted models when
the reported data relied on different treatment indicators
or different services than those modelled. To make these
adjustments, we first compared the products and services
currently covered by PSI’s DALYs averted models to those
dispensed by non-PSI social franchises. Nine of the non-
PSI programs reported the number of TB cases initiated
on treatment rather than the number of TB cases com-
pleting treatment, a key distinction in the parameter used
by the PSI TB DALYs averted model. Published correla-
tions between reported outcomes (e.g., initiation of TB
treatment) and outcomes needed for the DALYs averted
model (e.g., treatment completion) guided the extrapola-
tion of estimates for the non-PSI programs. We estimated
completion rates using an average of 89.6% of TB treat-
ment initiations, based on a WHO-led meta-analysis of
public-private TB initiatives [26].
In one instance, we adjusted data by excluding data in
one year because the data did not match the criteria
required by the models. The PSI HIV Counseling and
Testing (HCT) DALYs averted model for HIV counseling
and testing distinguishes between six categories of patients
receiving HIV voluntary counseling and testing services:
HIV-negative and single; HIV-positive and single; HIV-
negative in a concordant couple; HIV-positive in a concor-
dant couple; HIV-negative in a discordant couple; and
HIV-positive in a discordant couple. As non-PSI programs
did not collect data on partner status in 2010, our analysis
excluded their reported HCT data. We included these
data from 2011, as a more detailed survey instrument
recorded partner status from HCT client interactions.
A final set of adjustments concerned those non-PSI
social franchising programs which dispensed products or
services that are not currently supported by PSI’s DALYs
averted models. Examples of such services include labor
and delivery, pediatric consultations, menstrual regulation
services, and vaccinations. These products and services
were not included in our analysis.
Comparisons across years and regions
Social franchise networks were analyzed by size based
on the number of outlets that were reported for each
year. We used ANOVA to compare the average size of
franchises across the regions.
We compared the sum of each of the metrics - ser-
vices provided, DALYs averted, CYPs, and patient
volume - for 2010 and 2011 for all of the social fran-
chise programs reporting in each year and by region.
We report the percent change from 2010 to 2011 for
each of these metrics, including the changes by region.
For statistical analysis, we used a paired t-test to detect
differences in the metrics as reported across the two
years by each of the social franchising networks. This
test was intended to identify a common shift toward
either increased or decreased output among those net-
works reporting data in both 2010 and 2011 (N = 32)
for each metric. To understand the overall percent
change for family planning and non-family planning ser-
vices, we isolated services related to family planning
from the programs reporting these data in both years (n
= 30), summing up each of the metrics and considering
the percent change over the two years. For statistical
analysis, we again used a paired t-test to identify com-
mon differences year to year. We followed the same
procedure for analyzing non-family planning services.
Nineteen franchises were compared in the paired t-test.
In addition, we aggregated DALYs averted within pro-
gram areas by region. All services were categorized into
one of the following major program areas: family planning,
sexual and reproductive health, maternal and child health,
HIV/AIDS, malaria, diarrhea, acute respiratory disease,
and tuberculosis.
To check reporting quality, we compared services pro-
vided to patient volume using a Pearson’s correlation
coefficient. Certainly, a weak relationship between ser-
vices provided and the number of patient visits may not
always indicate poor reporting. The relationship between
these two metrics could be weak if different franchise
networks offer different numbers of integrated services
per patient. Moreover, it is worth noting that the unit of
service may vary across interventions. For example, a
year’s supply of oral contraceptives would be counted as
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13 services whereas one IUD would be counted as a sin-
gle service, even though it is expected to protect against
unintended pregnancy for longer than a year. Type of
service, therefore, may affect the ratio between services
provided and patient volume.
Results
Description of sample for analysis
Thirty-two franchise networks were represented in the
set of services for which DALYs averted or CYPs pro-
vided could be calculated for the years 2010 and 2011.
Networks included in the analysis represented 23 coun-
tries. Over the two years, these franchises reported
1,121,352,473 services provided through 22,941,811
patient visits. Additional file 3 shows a summary of
reported data for all franchise networks in the analysis.
Size of social franchising networks by region
Franchise networks in Asia tended to be larger than their
counterparts in Latin America and Africa. On average, the
number of outlets was different across the three regions
for both years (ANOVA, p < .05). Asian social franchise
programs had an average of 2,708 outlets across franchise
networks in 2010. For the same year, Latin America had
an average of 606 outlets and Africa had an average of 114
outlets. Number of outlets was not significantly different
in 2011 compared to 2010 for any of the regions.
Changes across the social franchising networks,
2010 to 2011
The years, 2010 to 2011, saw growth in social franchising
across the set of networks, measured by output and
impact. During this time, the services provided increased
by 215% across the 32 franchise networks (Table 1). Asia
and Africa saw considerable growth, 245% and 189%
respectively, although African networks reported fewer
than half the number of services provided overall com-
pared to the Asian networks. For the 32 networks, the
number of patient visits increased by 31% and CYPs rose
by 86% over the two years. The number of DALYs averted
grew by 519% across the full set of networks, with varia-
tion by region. African franchise networks reported the
greatest change in DALYs averted, a 538% increase.
Latin America experienced a decline in services provided
which also produced a decline in DALYs averted and
CYPs. With just three countries (El Salvador, Guatemala,
and Peru) offering small family planning programs, this
region’s social franchise programs are limited in size and
scope, making its aggregate health impact results sensitive
to shifts in individual programs, or program reporting. In
this case, the exclusion of Guatemala’s non-franchise con-
dom distribution efforts, inappropriately included in 2010,
reduced the number of DALYs averted in Latin America
by two-thirds in 2011.
Over the two years, services in the franchise networks
diversified; non-family planning services increased by
857% (Table 2). While these diverse types of interventions
comprised 18% of the reported services provided in 2010,
this percentage more than doubled in 2011 to 55% of the
services provided by the franchises. Asian franchise net-
works saw the greatest increase in non-family planning
services, from just 2% of the services reported for 2010 to
50% in 2011. African social franchising programs initially
offered more diversity in its service portfolio than other
regions, reporting a higher percentage of non-family plan-
ning services in 2010, 56%. Even so, these African net-
works still continued to diversify in 2011, increasing to
68%. Latin American social franchising programs were
almost exclusively focused on family planning in both
years. The change in DALYs averted by these services cor-
responded to the differences shown in the changes in ser-
vices provided (Table 3). Note that the magnitude of
change varies because each country’s burden of disease is
factored into the calculation of DALYs averted.
Significance of program output and impact changes,
2010-2011
In paired t-tests comparing the output and impact
metrics from the 32 social franchise programs that
reported sufficient data for both years, we did not detect
Table 1 Change in number of services provided, DALYs
averted, CYPs, and patient volume for products and
services eligible for analysis, 2010-11, by region
Region 2010 2011 % Change
Asia (n = 13)
Services provided 178,386,749 615,368,041 245%
DALYs averted 865,187 5,306,229 513%
CYPs 5,749,247 7,934,530 38%
Patient volume 7,605,797 10,149,492 33%
Africa (n = 16)
Services provided 81,368,197 235,315,665 189%
DALYs averted 691,776 4,411,879 538%
CYPs 892,064 4,693,329 426%
Patient volume 1,698,731 2,235,235 32%
Latin America (n = 3)
Services provided 10,537,887 375,934 -96%
DALYs averted 14,770 3,645 -75%
CYPs 183,640 90,854 -54%
Patient volume 626,376 626,278 0%
Total (N = 32)
Services provided 270,292,833 851,059,640 215%
DALYs averted 1,571,733 9,721,752 519%
CYPs 6,824,951 12,718,714 86%
Patient volume 9,930,806 13,011,005 31%
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significant change in the total number of services pro-
vided, DALYs averted, or CYPs. While high degrees of
year-to-year variation occurred within a small number
of programs, the changes showed both increases and
decreases, and led to no common difference across pro-
grams. Similarly, no common difference was evident in
the sum of services provided which we had categorized
as family planning and non-family planning.
Social franchising program impact in program areas
by region
Social franchising programs within the Compendia also
show wide variation in the number of DALYs averted dur-
ing this time period, with variation by program area and
by region. The aggregate total for each social franchising
program differed greatly, ranging from 110 to 3,340,046
DALYs averted in Africa, and from 1,721 and 4,528,341
DALYs averted in Asia. When analyzed by health program
area and region, the total number of DALYs averted also
spans a range of results as shown in Table 4. While the
number of DALYs averted through reproductive health
interventions in Asia grew considerably over the two
years, the greatest increase in DALYs averted for Asia was
through interventions that target diarrhea. No network in
Asia reported products and services in this program area
in 2010. In 2011, other social franchising networks
reported large numbers of DALYs averted due to diarrhea
treatment services. In 2011, one network in Asia generated
nearly 4 million DALYs averted from its distribution of
over 300 million ORS sachets while another delivered over
4 million diarrhea services (4,042,613 ORS sachets), yield-
ing 47,913 DALYs averted.
In Africa, the program area of malaria experienced the
most dramatic increases in DALYs averted. Over the
two-year period, six different franchises reported ser-
vices targeting malaria, with the number of DALYs
averted increasing from 145,453 in 2010 to 3,082,540 in
2011. The efforts of a single network accounted for this
considerable increase. This social franchise distributed
over 9 million (9,053,386) long-lasting, insecticide-trea-
ted bednets in 2011, averting 3 million DALYs over the
life of the nets.
Program reporting consistency
The ratio of the reported number of services provided
to the reported number of patient visits for each year
offers a data quality check on franchise reporting. While
services provided were significantly correlated with the
number of outlets in 2010 (r = .418, p < .05) but not in
2011, these data showed a significant correlation with
patient volume in both 2010 and 2011 (r = .696, p < .05;
r = .383, p < .05, respectively). The variation in the ratio
of services provided to patient volume was seen across
all three regions and even across years for single fran-
chises. We analyzed 64 pairs of services provided and
patients visits. We derived this number by taking each
annual report from the franchises separately and remov-
ing one annual report from a franchise that failed to
report patient visits for a single year. Forty-one annual
franchise reports included less than ten services pro-
vided per patient visit, predominately less than two.
Thirteen annual reports included more than 100 ser-
vices provided per patient visit, up to 16,632 for one
franchise. Among the franchises that reported ratios
greater than 100:1, only two reported such high ratios
for both years. Note that program affiliation did not
determine the high variation, as it occurred among both
PSI and non-PSI social franchises.
Discussion
This evaluation sought to demonstrate the application of
using DALYs averted as a standard health impact metric
for social franchising. Our results show it is possible to
Table 2 Change in family planning services versus non-
family planning services, 2010-11, by region
Region 2010 2011 % Change
Asia (n = 13)
Family planning services 174,552,468 305,929,488 75%
Other services 3,834,281 309,438,553 2676%
Africa (n = 16)
Family planning services 36,032,303 74,355,350 106%
Other services 45,335,894 160,960,315 255%
Latin America (n = 3)
Family planning services 10,537,434 375,934 -96%
Other services 453 na -100%
Total (N = 32)
Family planning services 221,122,205 380,660,772 72%
Other services 49,170,628 470,398,868 857%
Table 3 Change in DALYs averted from family planning
services versus non-family planning services, 2010-11,
by region
Region 2010 2011 % Change
Asia (n = 13)
Family planning DALYs averted 709,484 1,005,291 42%
Other services DALYs averted 155,703 4,300,939 2,662%
Africa (n = 16)
Family planning DALYs averted 311,289 944,939 204%
Other services DALYs averted 380,487 3,466,940 811%
Latin America (n = 3)
Family planning DALYs averted 14,759 3,645 -75%
Other services DALYs averted 11 0 -100%
Total (N = 32)
Family planning DALYs averted 1,035,532 1,953,874 89%
Other services DALYs averted 536,201 7,767,878 1,349%
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apply a metric based on the DALY to service delivery
data from multiple social franchising programs, whether
DALYs averted is a new metric for these programs or
not. As calculation of the DALYs averted metric just
requires social franchise service delivery data as well as
sufficient data on disease burden for a country, the PSI
DALYs averted models could be applied to non-PSI
social franchise data. In some cases, we could not esti-
mate DALYs averted because we did not have sufficient
information reported on a franchise program’s interven-
tions, such as the number of services provided or what
specific disease was targeted. In other cases, we lacked
country-specific data, such as disease prevalence, and
also could not estimate DALYs averted. However, most
social franchises in the Social Franchising Compendia
appear to report sufficient detail in service delivery data,
and operate in countries in which disease burden data
are available. Therefore, as demonstrated, the conversion
of this service delivery data into DALYs averted is feasi-
ble for global social franchising programs.
Our findings also support the theoretical basis for adopt-
ing DALYs averted as a summary measure of program
health impact: this new metric can be applied to project
health impact across a range of products and services.
While patient volume and number of outlets are impor-
tant process metrics for tracking program progress, they
do not indicate health impact. The CYP metric, while
commonly understood as a comprehensive measure of
program impact unlike these process measures, is actually
based on intervention protection and is not context-speci-
fic in terms of pregnancy risk in a population. Moreover,
the CYP’s measurement is limited to family planning ser-
vices. As demonstrated in this study’s analysis of DALYs
averted by service type and program area, many social
franchising programs offer a diverse mix of services that
cannot be measured by CYPs. Certainly, large numbers of
DALYs averted from 2010-11 can be attributed to family
planning (likely reflecting the reproductive health origins
of many social franchising programs). However, treatment
and services for health conditions not incorporated in
CYPs - but with high importance to current burden of dis-
ease [18] and offered by a growing number of social fran-
chise programs - are important drivers of DALYs averted.
DALYs averted, therefore, enables social franchisors to
capture a diverse array of health services when estimating
health impact.
On account of this new metric’s wide applicability, the
importance of DALYs averted as a summary measure of
health impact may be most notable for social franchising
programs in which non-family planning services contri-
bute significantly to overall treatment numbers. For pro-
grams where family planning is the focus of all or nearly
all of the services provided, a shift to DALYs averted is
likely to offer only limited improvement in measurement
of impact, resulting from the country context adjustments
in the family planning DALYs averted model. However,
given the current trend in LMICs to broaden clinic offer-
ings beyond specialized, family planning-only services to
more integrated and comprehensive care, the benefit of
using DALYs averted as the standard health impact metric
for social franchising is likely to grow in the future.
In addition to capturing the impact of clinics offering
diversified services, the adoption of DALYs averted offers
benefits for social franchisors and their stakeholders in
programmatic decision making. When tracking ongoing
progress and the overall impact of service delivery, social
franchisors can calculate, and then compare, DALYs
averted at different levels of the network structure. For
example, they can compare impact between individual
health services, or sum up the DALYs averted from all
services to compare the performance of individual clinics
within the network. The aggregate health impact estimate
also enables benchmarking of an entire franchise net-
work’s performance between programs, countries, and
regions, comparisons that are currently only possible in
social franchising for family planning impact. As the
Table 4 DALYs averted from social franchise program service delivery, 2010-11, by program area and region




DALYs Averted by Latin
American Programs


















Family Planning 709,484 1,005,291 311,289 944,939 14,759 3,645 1,035,532 1,953,874
Sexual and Reproductive Health 38,161 32,865 66,354 184,235 11 104,527 217,100
Maternal and Child Health 76,551 76,551
HIV 131 232 128,700 121,977 128,831 122,209
Malaria 38,955 38,872 145,453 3,082,540 184,408 3,121,411
Diarrhea 2,440 4,066,699 36,495 25,167 38,935 4,091,865
Acute Respiratory Illness 8,340 13,820 52,341 8,340 66,160
Tuberculosis 67,675 71,900 3,485 681 71,160 72,581
Total DALYs averted 865,187 5,306,229 691,776 4,411,878 14,770 3,645 1,571,733 9,721,752
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DALYs averted metric incorporates disease burden - and
thus, population need - into its impact estimates, social
franchisors can use DALYs averted data to help deter-
mine which services to emphasize in a particular catch-
ment area, country, or region. While service delivery data
can show demand, the potential number of DALYs
averted is a better indicator of health needs, and ulti-
mately, health impact.
The DALYs averted metric can also be interpreted
alongside other data to reflect program aims and values.
The cost per DALY averted is a common indicator of
cost-effectiveness. With cost data from a franchising net-
work or for outlets within a franchise, franchise managers
can drive toward increased efficiency. A franchise-specific
net cost per DALY averted can help social franchisors
and stakeholders better consider the opportunities and
trade-offs of specific service delivery interventions, lead-
ing to greater optimization of care.
Limitations
Deriving DALYs averted relies on complete and accurate
service delivery data, the key limitation of this study. We
found evidence of inconsistent service outcome reporting
in approximately 10% of programs. Certainly, errors in
program reporting are likely present in all health impact
measures, making cross-program comparisons inherently
challenging. We believe these comparisons are neverthe-
less still worth attempting. This analysis, and our past
experience with many programs, gives us no reason to
believe there is systematic and intentional misrepresenta-
tion of service delivery information. Rather, as the Social
Franchising Compendia aims to include all clinic services
provided by its member networks, reporting variations
are likely due to poor specification of what data need to
be collected.
One implication of the variability identified, however, is
that the changes identified through our analysis of 2010-
2011 data in DALYs averted and patients seen should be
interpreted as indicative rather than absolute. The varia-
bility seen here is indicative of changes in the application
of franchising as a delivery platform worldwide, rather
than changes within specific programs.
Likewise, confusion about the distinction between those
health services provided through social franchising versus
social marketing distribution channels also persists. The
services provided by social franchising programs are
clinic-based and include clinical interventions, counseling,
and commodity sales. Many clinical interventions, such as
IUD insertions, involve one service provided during a sin-
gle patient visit. Many commodity sales (condoms, cycles
of contraceptive pills, or others) could involve large num-
bers of ‘services’ provided during a single patient visit.
Social marketing is based on commodities only. While
social marketing interventions will often involve the same
commodities as those in social franchising, these products
are usually delivered through non-clinic retail outlets and
do not involve patient visits. Despite differences in delivery
modality, the two intervention approaches use related
market-based models, leading many implementing organi-
zations to operate both, often with the two delivery sys-
tems sharing the same overall brand of commodities (e.g.,
PSI’s PUR water treatment product to prevent diarrhea).
As a result, confusion in reporting is likely to occur, as
suggested by the data used in this study. One notable
example of these reporting errors can be seen in some
outlier data on commodity sales. In both 2010 and 2011,
some social franchising programs stand out as having
exceptionally high rates of commodity sales - primarily
anti-malarial bednets (LLINs), ORS, and condoms - result-
ing in some of the highest DALYs averted numbers from
individual services in our study, as well as year-on-year
volatility in the data. For example, one program in Africa
serving approximately 700,000 patients reported the distri-
bution of over 9 million LLINs in a single year. Another
program, treating 1.27 million patients in Asia, noted that
it delivered over 300 million ORS sachets one year, over
250 sachets per patient. Such high figures suggest that a
number of programs are erroneously including non-clinic
retail outlet social marketing distribution figures in their
social franchising reporting, as we know was the case for a
PSI Guatemala program in 2010 that erroneously included
non-clinic condom sales in its service delivery data. More-
over, this high year-to-year variation in commodity sales
occurs while the number of patient visits remains stable.
The high ratios of services to patient volume, particularly
those programs with 50:1 or even 16,000:1 ratios, are likely
due to an amalgamation of social marketing and social
franchising outputs when reporting. Clearer guidelines on
the collection and reporting of service delivery data,
including how to distinguish between commodities deliv-
ered via social franchising versus social marketing chan-
nels, are needed to minimize reporting errors in the
future. Follow up with outlier programs will also be
beneficial.
Another limitation of our analysis is that a number of
medical services remain uncounted in our DALYs
averted metric, notably antenatal care and safe deliveries.
This omission under-credits social franchising programs
delivering these services in terms of health impact. If
DALYs averted is to become more widely used in social
franchising, new DALYs averted models must be devel-
oped for these services.
This study is also limited by the models themselves as
well as the data fed into them. Determining the number
of DALYs averted by an intervention is difficult, requiring
complex modeling of the specific burden of disease in
each country, and of the effectiveness and health out-
comes of each intervention. To create these models,
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accurate treatment data and population information are
essential, yet sometimes challenging to obtain in the
LMIC settings where this metric is applied. PSI needs to
use proxies and best estimates for some model para-
meters such as treatment use and wastage, as well as
extrapolate population data from nearby countries when
local data are unavailable. In addition, development and
maintenance of the models has required a considerable
investment by PSI. Moving to a broader set of interven-
tions and pressure to develop new models has sometimes
compromised the maintenance of models that need to be
updated continuously.
Conclusion
Despite more than a decade of the global health com-
munity using DALYs as a measurement of disease bur-
den, the application of this metric for projecting health
program impact is still in its nascent stages. For the
rapidly emerging social franchise service delivery model,
our analysis finds a strong theoretical basis for adopting
DALYs averted as its program impact metric. DALYs
averted is likely to be the most inclusive and compre-
hensive measurement available, enabling inter- and
intra-program comparisons for tracking program pro-
gress and guiding strategic planning and program
design. In theory as well as in practice, DALYs averted
captures the impact of a wide range of health care ser-
vices, not limited to the delivery of family planning
methods, and thus best represents the breadth of care
and treatment offered by a majority of social franchise
programs. Our analysis supports this conclusion, even
while we found that the application of the DALYs
averted remains problematic given current challenges in
data reporting and the burden of expanding model
development.
The social franchising community of practice offers a
useful forum to pilot the DALYs averted metric as a stan-
dardized measure for service delivery programs managed
by multiple implementing organizations. First, the diver-
sity of health services offered by social franchisors
enables opportunities for learning how to best measure
program impact in different program areas. Second, the
established platform for collaboration and transparent
data sharing provides a forum, such as that found in the
Social Franchising Compendia, for improving and
streamlining data management systems. Certainly, con-
siderable work still needs to be done to assure that ser-
vice delivery data collected by programs are based on
shared parameters and are not subject to the vagaries of
interpretation during data entry as appears to have
occurred in 2010 and 2011. Motivated by shared interests
and the attraction of collaborative work, members of the
social franchising community are currently collaborating
on developing standards to address these reporting
issues. Once this process is accomplished, we expect
the social franchising community of practice to be well-
positioned to begin using, and eventually standardizing,
DALYs averted as its metric for estimating programmatic
health impact in all service areas.
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